Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.

por Lancaster, J. M., Berchuck, A., Carney, M. E., Wiseman, R., Taylor, J. A.
Publicado 1998

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

por Lancaster, J. M., Carney, M. E., Gray, J., Myring, J., Gumbs, C., Sampson, J., Wheeler, D., France, E., Wiseman, R., Harper, P., Futreal, P. A.
Publicado 1998

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival

por Bicaku, E, Xiong, Y, Marchion, D C, Chon, H S, Stickles, X B, Chen, N, Judson, P L, Hakam, A, Gonzalez-Bosquet, J, Wenham, R M, Apte, S M, Fulp, W, Cubitt, C L, Chen, D-T, Lancaster, J M
Publicado 2012